Evidence map›Paper›PMID 38260911›Full record

ReviewFrontiers in microbiology2023

Active substances of myxobacteria against plant diseases and their action mechanisms.

Lele Zhang, Liangliang Bao, Songyuan Li, Yang Liu, Huirong Liu

Erratum issuedOpen access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
6.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. PredatoryFrontiers in microbiology · 2026
    Article
  3. Biocontrol of watermelon Fusarium wilt caused byFrontiers in microbiology · 2026
    Article
  4. Frontiers in microbiology · 2025
    Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lele ZhangCollege of Life Sciences, Inner Mongolia Agricultural University, Hohhot, Inner Mongolia, China.
Liangliang BaoCollege of Science, Inner Mongolia Agricultural University, Hohhot, Inner Mongolia, China.
Songyuan LiCollege of Life Sciences, Inner Mongolia Agricultural University, Hohhot, Inner Mongolia, China.
Yang LiuCollege of Life Sciences, Inner Mongolia Agricultural University, Hohhot, Inner Mongolia, China.
Huirong LiuCollege of Life Sciences, Inner Mongolia Agricultural University, Hohhot, Inner Mongolia, China.
Inner Mongolia Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myxobacteria have a complex life cycle and unique social behavior, and obtain nutrients by preying on bacteria and fungi in soil. Chitinase, β-1,3 glucanase and β-1,6 glucanase produced by myxobacteria can degrade the glycosidic bond of cell wall of some plant pathogenic fungi, resulting in a perforated structure in the cell wall. In addition, isooctanol produced by myxobacteria can lead to the accumulation of intracellular reactive oxygen species in some pathogenic fungi and induce cell apoptosis. Myxobacteria can also perforate the cell wall of some plant pathogenic oomycetes by β-1,3 glucanase, reduce the content of intracellular soluble protein and protective enzyme activity, affect the permeability of oomycete cell membrane, and aggravate the oxidative damage of pathogen cells. Small molecule compounds such as diisobutyl phthalate and myxovirescin produced by myxobacteria can inhibit the formation of biofilm and lipoprotein of bacteria, and cystobactamids can inhibit the activity of DNA gyrase, thus changing the permeability of bacterial cell membrane. Myxobacteria, as a new natural compound resource bank, can control plant pathogenic fungi, oomycetes and bacteria by producing carbohydrate active enzymes and small molecular compounds, so it has great potential in plant disease control.

Indexed as

biological controlcarbohydrate-active enzymesmyxobacteriaplant diseasessmall molecule compounds

Identifiers

PMID38260911
PMCPMC10800785
OpenAlexW4390665537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.